Ceritinib and cabozantinib: new tyrosine kinase inhibitors improve treatment options for non-small cell lung cancer patients

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

Annals of Oncology ◽

10.1093/annonc/mdn240 ◽

2008 ◽

Vol 19 (9) ◽

pp. 1605-1612 ◽

Cited By ~ 55

Author(s):

P.A. Zucali ◽

M.G. Ruiz ◽

E. Giovannetti ◽

A. Destro ◽

M. Varella-Garcia ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

P2.03-013 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1264 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2132

Author(s):

K. Chen ◽

X. Yu ◽

H. Wang ◽

Z. Huang ◽

Y. Xu ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

1205P Treatment sequencing and duration of subsequent tyrosine kinase inhibitors in ALK+ non-small cell lung cancer patients treated with brigatinib in the US

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1810 ◽

2021 ◽

Vol 32 ◽

pp. S960-S961

Author(s):

M.O. Jahanzeb ◽

H.M. Lin ◽

Y. Wu ◽

M. Gorritz ◽

C.B. McGuiness ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

The Us ◽

Treatment Sequencing

Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients with EGFR Positive Mutations

Indian Journal of Forensic Medicine & Toxicology ◽

10.37506/ijfmt.v15i3.15970 ◽

2021 ◽

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: A systematic review

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2015.05.005 ◽

2015 ◽

Vol 41 (7) ◽

pp. 634-645 ◽

Cited By ~ 22

Author(s):

Lizza E.L. Hendriks ◽

Janna Schoenmaekers ◽

Jaap D. Zindler ◽

Danielle B.P. Eekers ◽

Ann Hoeben ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Cranial Radiotherapy ◽

Lung Cancer Patients

Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations

Scientific Reports ◽

10.1038/srep06104 ◽

2014 ◽

Vol 4 (1) ◽

Cited By ~ 26

Author(s):

Liang Peng ◽

Zhi-Gang Song ◽

Shun-Chang Jiao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Efficacy Analysis

Efficacy of tyrosine kinase inhibitors in non-small-cell lung cancer patients undergoing dose reduction and those with a low body surface area

Molecular and Clinical Oncology ◽

10.3892/mco.2014.281 ◽

2014 ◽

Vol 2 (4) ◽

pp. 604-608 ◽

Cited By ~ 10

Author(s):

SHINYA SATO ◽

KOICHI KURISHIMA ◽

KUNIHIKO MIYAZAKI ◽

TAKAHIDE KODAMA ◽

HIROICHI ISHIKAWA ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Dose Reduction ◽

Cancer Patients ◽

Body Surface ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Treatment of Non-Small Cell Lung Cancer Patients in the Intensive Care Units with EGFR-Tyrosine Kinase Inhibitors

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2454 ◽

2020 ◽

Author(s):

I.H. Lee ◽

C.-Y. Yang ◽

J.-Y. Shih ◽

C.-J. Yu

Keyword(s):

Lung Cancer ◽

Intensive Care ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

JCES 01.18 Uncommon Mutation Types of EGFR and Response to EGFR Tyrosine Kinase Inhibitors in Chinese Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.305 ◽

2017 ◽

Vol 12 (11) ◽

pp. S1736-S1737

Author(s):

K. Chen ◽

X. Yu ◽

H. Wang ◽

Z. Huang ◽

Y. Xu ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?

Expert Opinion on Medical Diagnostics ◽

10.1517/17530059.1.2.183 ◽

2007 ◽

Vol 1 (2) ◽

pp. 183-191 ◽

Cited By ~ 2

Author(s):

Giovanna Finocchiaro ◽

Luca Toschi ◽

Isabella Garassino ◽

Fabio De Vincenzo ◽

Elisabetta Campagnoli ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽